Procyon Advisors LLC Grows Stock Holdings in Lam Research Corporation $LRCX

Procyon Advisors LLC raised its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 79.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,618 shares of the semiconductor company’s stock after purchasing an additional 11,348 shares during the quarter. Procyon Advisors LLC’s holdings in Lam Research were worth $4,385,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the business. Stance Capital LLC bought a new position in shares of Lam Research in the 3rd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in Lam Research during the second quarter worth approximately $27,000. Triumph Capital Management purchased a new stake in Lam Research during the third quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at approximately $29,000. Finally, Delos Wealth Advisors LLC purchased a new position in Lam Research during the second quarter worth $30,000. 84.61% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

LRCX has been the subject of several analyst reports. Summit Insights upgraded shares of Lam Research from a “hold” rating to a “buy” rating in a report on Thursday, January 29th. JPMorgan Chase & Co. raised their price target on Lam Research from $165.00 to $300.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Susquehanna set a $325.00 price objective on Lam Research and gave the company a “positive” rating in a report on Thursday, January 29th. KeyCorp reaffirmed a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. Finally, Wells Fargo & Company increased their target price on Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $245.35.

Insider Buying and Selling

In related news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Eric Brandt sold 35,000 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 130,886 shares of company stock valued at $29,658,802 over the last 90 days. Corporate insiders own 0.31% of the company’s stock.

Lam Research Stock Down 2.4%

Shares of NASDAQ:LRCX opened at $228.36 on Friday. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $256.68. The stock has a market cap of $285.17 billion, a P/E ratio of 46.80, a price-to-earnings-growth ratio of 2.46 and a beta of 1.77. The business’s 50 day moving average is $226.92 and its 200 day moving average is $177.57. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business’s revenue was up 22.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is currently 21.31%.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.